Volume 16, Issue 3, Pages (September 2014)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 2, Pages (July 2009)
Advertisements

Jason M. Mackenzie, Alexander A. Khromykh, Robert G. Parton 
Volume 12, Issue 1, Pages (July 2012)
Volume 14, Issue 5, Pages (November 2013)
Volume 12, Issue 3, Pages (September 2012)
Volume 18, Issue 6, Pages (December 2015)
Volume 8, Issue 2, Pages (August 2010)
Anthony J. Cesare, Makoto T. Hayashi, Laure Crabbe, Jan Karlseder 
F11L-Mediated Inhibition of RhoA-mDia Signaling Stimulates Microtubule Dynamics during Vaccinia Virus Infection  Yoshiki Arakawa, João V. Cordeiro, Michael.
NMD: Nonsense-Mediated Defense
Volume 15, Issue 1, Pages (January 2014)
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 18, Issue 5, Pages (November 2015)
Volume 14, Issue 3, Pages (September 2013)
Volume 11, Issue 6, Pages (June 2012)
Jason M. Mackenzie, Alexander A. Khromykh, Robert G. Parton 
Volume 9, Issue 2, Pages (February 2011)
Rui Pedro Galão, Suzanne Pickering, Rachel Curnock, Stuart J.D. Neil 
Volume 13, Issue 6, Pages (June 2013)
DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA  Jason W. Upton, William J.
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 1, Issue 1, Pages (March 2007)
Entry of Bunyaviruses into Mammalian Cells
Volume 15, Issue 1, Pages (January 2014)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Volume 14, Issue 3, Pages (September 2013)
Volume 4, Issue 3, Pages (September 2008)
Volume 18, Issue 2, Pages (August 2015)
Volume 23, Issue 10, Pages (October 2015)
A Serpin Takes a Bite out of the Flu
Volume 10, Issue 2, Pages (August 2011)
Volume 36, Issue 4, Pages (April 2012)
Volume 43, Issue 6, Pages (September 2011)
Volume 5, Issue 3, Pages (March 2009)
Volume 20, Issue 5, Pages (November 2016)
Volume 13, Issue 2, Pages (February 2013)
Volume 9, Issue 6, Pages (June 2011)
The TRIM Family Protein KAP1 Inhibits HIV-1 Integration
Takashi Fukaya, Hiro-oki Iwakawa, Yukihide Tomari  Molecular Cell 
Hepatitis C Virus Subverts Liver-Specific miR-122 to Protect the Viral Genome from Exoribonuclease Xrn2  Cecilia D. Sedano, Peter Sarnow  Cell Host &
Nucleocapsid Phosphorylation and RNA Helicase DDX1 Recruitment Enables Coronavirus Transition from Discontinuous to Continuous Transcription  Chia-Hsin.
Volume 17, Issue 1, Pages (January 2015)
Volume 13, Issue 4, Pages (April 2013)
Ramiro E. Verdun, Laure Crabbe, Candy Haggblom, Jan Karlseder 
Volume 126, Issue 6, Pages (September 2006)
Volume 16, Issue 3, Pages (September 2014)
Volume 18, Issue 6, Pages (December 2015)
Lost in Translation: An Antiviral Plant Defense Mechanism Revealed
Volume 17, Issue 6, Pages (June 2015)
F11L-Mediated Inhibition of RhoA-mDia Signaling Stimulates Microtubule Dynamics during Vaccinia Virus Infection  Yoshiki Arakawa, João V. Cordeiro, Michael.
Volume 26, Issue 6, Pages (June 2007)
Urtzi Garaigorta, Francis V. Chisari  Cell Host & Microbe 
Volume 20, Issue 5, Pages (November 2016)
Poxviral B1 Kinase Overcomes Barrier to Autointegration Factor, a Host Defense against Virus Replication  Matthew S. Wiebe, Paula Traktman  Cell Host.
Volume 138, Issue 2, Pages (July 2009)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 5, Issue 6, Pages (December 2013)
Vaccinia Virus F11 Promotes Viral Spread by Acting as a PDZ-Containing Scaffolding Protein to Bind Myosin-9A and Inhibit RhoA Signaling  Yutaka Handa,
Inside Job: Viruses Transfer cGAMP between Cells
Diverse Herpesvirus MicroRNAs Target the Stress-Induced Immune Ligand MICB to Escape Recognition by Natural Killer Cells  Daphna Nachmani, Noam Stern-Ginossar,
Volume 12, Issue 4, Pages (October 2012)
Volume 30, Issue 4, Pages (April 2009)
Volume 9, Issue 2, Pages (February 2011)
Position-Dependent Function for a Tandem MicroRNA miR-122-Binding Site Located in the Hepatitis C Virus RNA Genome  Catherine L. Jopling, Sylvia Schütz,
Volume 18, Issue 2, Pages (August 2015)
Volume 21, Issue 3, Pages (March 2017)
Volume 14, Issue 1, Pages (July 2013)
Volume 2, Issue 5, Pages (November 2007)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Volume 20, Issue 2, Pages (August 2016)
Presentation transcript:

Volume 16, Issue 3, Pages 403-411 (September 2014) The Host Nonsense-Mediated mRNA Decay Pathway Restricts Mammalian RNA Virus Replication  Giuseppe Balistreri, Peter Horvath, Christoph Schweingruber, David Zünd, Gerald McInerney, Andres Merits, Oliver Mühlemann, Claus Azzalin, Ari Helenius  Cell Host & Microbe  Volume 16, Issue 3, Pages 403-411 (September 2014) DOI: 10.1016/j.chom.2014.08.007 Copyright © 2014 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2014 16, 403-411DOI: (10.1016/j.chom.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Genome-wide siRNA Screen Identifies Upf1 as a Restriction Factor for SFV (A) Schematic representation of the SFV genome, viral gene expression, and genome replication. The ZsG marker gene is indicated in green. Translation of the +RNA genome gives rise to the viral replicase complexes, which subsequently produce the complementary −RNA. The −RNA is in turn used to amplify the RNA genome and to transcribe the subgenomic RNA. Proteolytic processing of the replicase determines the switch from − to +RNA synthesis. Right panel shows images of SFV-ZsG-infected HeLa cells at different times of infection (blue, nuclei; green, nsP3-ZsG). (B and C) Representative images from the SFV (B) and RSV (C) RNAi screen; the percentage of infected cells is indicated in white and the targeted genes are indicated below each image. For Upf1, images from two independent repetitions are shown (GW1 and GW2) (see also Figure S1). Cell Host & Microbe 2014 16, 403-411DOI: (10.1016/j.chom.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Upf1 Restricts Alphavirus Replication in HeLa Cells (A) Images of cells treated with indicated shRNAs and infected with SFV-ZsG for 4 hr. The viral products are visualized by direct fluorescence (nsP3-ZsG) or immunofluorescence (dsRNA and E1E2). (B) Western blot analysis of the Upf1 knockdown (KD) efficiency after shRNA treatment (from the same experiment shown in A). (C–E) Relative infection levels in cells treated with indicated shRNAs and infected with SFV-ZsG (C), SFV-RLuc (D), or SINV (E). The indicated viral products were monitored by image-based (C and E) or renilla luciferase (D) assays. (F) Effect of Upf1 KD in cells infected with SFV by low-pH-induced fusion with the plasma membrane. Infected cells are detected by dsRNA immunostaining. (G) Viral yields after Upf1 KD (24 hpi). (H) Image-based detection of single incoming viral genomes by branched-DNA FISH in cells infected with SFV ts9 at 40°C for 30 min. After fixation, cells were visualized by propidium iodide staining (PI). (I) Kinetics of genomic RNA decay in cells treated with shRNA against UPF1 or luciferase (sh-contr.) (see also Figure S2). Cell Host & Microbe 2014 16, 403-411DOI: (10.1016/j.chom.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Impairing Virus Replication Increases the Sensitivity to Upf1 in HeLa and Primary Cells (A) Schematic representation of SFV-Rluc-Ts9 genome and efficiency of virus replication at 36°C as measured by renilla luciferase assay. The mutation that confers the temperature-sensitive phenotype is indicated. (B) Immunostaining of dsRNA in HeLa cells infected for 4 hr with the indicated viruses at 36°C. (C and D) Efficiency of nsPs, dsRNA, and E1E2 production in HeLa (C) and neonatal human dermal fibroblast (HDFn) (D) cells infected with SFV-Rluc-Ts9 at 36°C for 4 hr. Representative images of HDFn treated with indicated shRNAs and immunostained for dsRNA at 4 hr postinfection. (E) Virus production after Upf1 depletion in HeLa cells infected with indicated viruses for 24 hr. Cell Host & Microbe 2014 16, 403-411DOI: (10.1016/j.chom.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Depletion of Smg5 and Smg7 Increases SFV Infection (A) Representative images of dsRNA-immunostained HeLa cells infected with SFV for 4 hr. Cells were pretreated with indicated shRNAs as in Figure 2. Nine images were acquired for each sample. (B) Relative infection in cells treated as in (A) and processed by quantitative image analysis. (C) Single-molecule fluorescence imaging of HeLa cells pretreated with indicated shRNAs and infected for 4 hr with equivalent amounts of SFV-ZsG (left panel) or SFV-ZsG virus-like particles with a short 3′ UTR (right panel). (D) Quantification of the intensity of ZsG fluorescence in the infected cells as in (C) (error bars represent the standard deviation of three independent experiments) (see also Figure S3). Cell Host & Microbe 2014 16, 403-411DOI: (10.1016/j.chom.2014.08.007) Copyright © 2014 Elsevier Inc. Terms and Conditions